Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|July 3, 1996

Universal Medical buys vascular firms

Universal Medical Systems of Clearwater, FL, has acquired threefirms that manufacture Pulse Volume Recorder, a device used todiagnose lower extremity arterial disease. UMSI purchased LifeSciences and two related companies, Biometrix New Hampshire

Universal Medical Systems of Clearwater, FL, has acquired threefirms that manufacture Pulse Volume Recorder, a device used todiagnose lower extremity arterial disease. UMSI purchased LifeSciences and two related companies, Biometrix New Hampshire andBiometrix Connecticut, for cash and about $650,000 in preferredstock.

Biometrix is developing Telepulse, a next-generation vasculardiagnostic system that includes a telemedicine capability by allowingattending physicians to transmit data for interpretation by aradiologist or vascular surgeon. The product has been clearedby the Food and Drug Administration and should be introduced inthe second half of 1996.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.